CClinicalTrials.gg
Status unknownNCT05467644Updated Jul 20, 2022

Treatment of Fracture Related Infection in Latin America.

An observational study in Fracture, Osteomyelitis and Soft Tissue Injuries, sponsored by Manoel Victorino Hospital. Status unknown at 1 site in Brazil. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2022-07-20.

Sponsored by Manoel Victorino Hospital · Observational

The sponsor has not verified this record recently (last verified Jul 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
300
Ages
16 Years and older
Sex
All
01

Study summary

Postoperative bone infection is a severe complication in the treatment of fractures and is more frequent than in elective joint replacement surgeries. Surgical treatment is based on meticulous debridement of bone and soft tissue, dead space management, soft tissue reconstruction when necessary, and restoration of bony stability in the non-union fracture. In addition, local antibiotic therapy is recommended in certain circumstances. This study aims to evaluate the results of surgical treatment of fracture-related infection in Latin America.

Read the detailed description

Research question: What are the characteristics and the diagnostic and therapeutic approach of patients with fracture-related infections (FRI) managed in various centers in Latin America?

Objectives:

General objective Describe the treatment of FRI in different institutions in Latin America, emphasizing the diagnostic process and the surgical and medical approach to this type of patient.

Specific objectives:

To analyze the usefulness of the criteria proposed by the expert consensus for diagnosing FRI.

Describe surgical treatment strategies in patients with FRI. Describe the microbiological profile of FRI in Latin American centers To explore variables associated with outcomes. Describe strategies for managing soft tissue defects associated with FRI. Describe the results regarding patients' quality of life with FRI.

Methodology:

Type of study: Observational retrospective cohort study

Outcomes to evaluate:

Infectious relapse: Presence of confirmatory or suggestive clinical signs of infection related to fractures, according to the FRI consensus criteria, within the first year of follow-up after the main surgery for the treatment of infection, and that motivates an intervention additional (Surgery or additional antibiotics) Consolidation: defined as clinical and radiological consolidation. Clinical consolidation - the absence of pain on local palpation and with load or walking. Radiological consolidation - Presence of bone trabeculae in the fracture line in the four cortices of the two standard radiological projections.

Complications: Defined as any adverse event that requires surgery for treatment. It can be "immediate" (those requiring an additional surgical procedure within up to 30 days of treatment of the infection. Examples: hematoma, debridement, change of fixators, change of implant, even if partial) or "late" ( those that required surgical procedure after 30 days of definitive treatment (for example debridement, implant failure, bone grafting).

Proposed statistical analysis: Descriptive statistics tools will be used for qualitative variables, absolute and relative frequencies, quantitative variables, measures of central tendency such as mean or median, and measures of dispersion such as standard deviation or interquartile range, according to the distribution of the variables. Univariate analyses will be performed to explore the relationship of different variables with the risk of infectious relapse, treatment failure, and amputation. All statistical analyzes will be executed in SPSS Statistics® v20 (IBM, Chicago, IL).

02

Conditions studied

  • Fracture
  • Osteomyelitis
  • Soft Tissue Injuries
  • Bone Loss

Keywords

  • Fracture
  • Osteomyelitis
  • Soft Tissue Injuries
  • Bone Loss
03

In context

Osteomyelitis

113 studies on the registry are indexed under Osteomyelitis; 33 are open to participants now.

This study's planned enrollment of 300 is above the median of 100 across 50 observational studies indexed under Osteomyelitis.

Browse Osteomyelitis studies →

Lead sponsor

This is the only study on the registry with Manoel Victorino Hospital as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients diagnosed with Fracture-related Infection

Inclusion criteria

  • Adult patients (18 years or older)
  • Infection after surgical fracture treatment occurred 90 days after the initial surgery.
  • Definitive treatment in one of the centers involved
  • Hospital admission from January 1, 2018, to December 31, 2020
  • Minimum outpatient follow-up period of one year after the main surgery to treat the infection, assess the quality of life, and control of the infection.

Exclusion criteria

Exclusion Criteria:

  • Incomplete medical records
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
300 participants (estimated)
Patient registry
No

Interventions

  • ProcedureTreatment of Fracture Related Infection

    Observational Retrospective Study. Only one group. Patients diagnosed with fracture-related infection and submitted to surgical treatment

06

What researchers measure

Primary outcomes

  1. Usefulness of the FRI diagnosing criteria

    To analyze the usefulness of the criteria proposed by the expert consensus for diagnosing fractures-related infections.

    Time frame: at least 6 months after infection treatment

Secondary outcomes

  1. Surgical treatment

    Describe the strategies of surgical treatment in patients with infections related to fractures

    Time frame: at least 12 months after infection treatment

  2. Microbiological profile

    Describe the microbiological profile of fracture-related infections in Latin American centers.

    Time frame: just after infection treatment

  3. Variables associated with outcomes

    To explore variables associated with the outcome of fracture-related infection control

    Time frame: at least 12 months after infection treatment

  4. Strategies for the management of soft tissue defects

    Describe the strategies for the management of soft tissue defects associated with infections related to fractures.

    Time frame: at least 6 months after infection treatment

  5. Quality of life - EQ-5D-3L

    Describe the results in terms of the quality of life of patients with infections related to fractures

    Time frame: at least 12 months after infection treatment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Walter G, Kemmerer M, Kappler C, Hoffmann R. Treatment algorithms for chronic osteomyelitis. Dtsch Arztebl Int. 2012 Apr;109(14):257-64. doi: 10.3238/arztebl.2012.0257. Epub 2012 Apr 6. PubMed 22536302 ↗
  • Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury. 2006 May;37 Suppl 2:S59-66. doi: 10.1016/j.injury.2006.04.010. PubMed 16651073 ↗
  • Steinmetz S, Wernly D, Moerenhout K, Trampuz A, Borens O. Infection after fracture fixation. EFORT Open Rev. 2019 Jul 15;4(7):468-475. doi: 10.1302/2058-5241.4.180093. eCollection 2019 Jul. PubMed 31423330 ↗
  • Alcantara JE JUNIOR, Aguiar RA, Sampaio JGL NETO, Azi ML, Sadigursky D, Alencar DF. FACTORS ASSOCIATED WITH THE DEVELOPMENT OF EARLY INFECTION AFTER SURGICAL TREATMENT OF FRACTURES. Acta Ortop Bras. 2018 Jan-Feb;26(1):22-26. doi: 10.1590/1413-785220182601173883. PubMed 29977139 ↗
  • Metsemakers WJ, Morgenstern M, McNally MA, Moriarty TF, McFadyen I, Scarborough M, Athanasou NA, Ochsner PE, Kuehl R, Raschke M, Borens O, Xie Z, Velkes S, Hungerer S, Kates SL, Zalavras C, Giannoudis PV, Richards RG, Verhofstad MHJ. Fracture-related infection: A consensus on definition from an international expert group. Injury. 2018 Mar;49(3):505-510. doi: 10.1016/j.injury.2017.08.040. Epub 2017 Aug 24. PubMed 28867644 ↗
  • Depypere M, Morgenstern M, Kuehl R, Senneville E, Moriarty TF, Obremskey WT, Zimmerli W, Trampuz A, Lagrou K, Metsemakers WJ. Pathogenesis and management of fracture-related infection. Clin Microbiol Infect. 2020 May;26(5):572-578. doi: 10.1016/j.cmi.2019.08.006. Epub 2019 Aug 22. PubMed 31446152 ↗
  • Zimmerli W, Sendi P. Orthopaedic biofilm infections. APMIS. 2017 Apr;125(4):353-364. doi: 10.1111/apm.12687. PubMed 28407423 ↗
  • Hotchen AJ, McNally MA, Sendi P. The Classification of Long Bone Osteomyelitis: A Systemic Review of the Literature. J Bone Jt Infect. 2017 Sep 12;2(4):167-174. doi: 10.7150/jbji.21050. eCollection 2017. PubMed 29119075 ↗
  • Morgenstern M, Moriarty TF, Kuehl R, Richards RG, McNally MA, Verhofstad MHJ, Borens O, Zalavras C, Raschke M, Kates SL, Metsemakers WJ. International survey among orthopaedic trauma surgeons: Lack of a definition of fracture-related infection. Injury. 2018 Mar;49(3):491-496. doi: 10.1016/j.injury.2018.02.001. Epub 2018 Feb 6. PubMed 29433799 ↗
  • Metsemakers WJ, Kuehl R, Moriarty TF, Richards RG, Verhofstad MHJ, Borens O, Kates S, Morgenstern M. Infection after fracture fixation: Current surgical and microbiological concepts. Injury. 2018 Mar;49(3):511-522. doi: 10.1016/j.injury.2016.09.019. Epub 2016 Sep 11. PubMed 27639601 ↗
  • Bezstarosti H, Van Lieshout EMM, Voskamp LW, Kortram K, Obremskey W, McNally MA, Metsemakers WJ, Verhofstad MHJ. Insights into treatment and outcome of fracture-related infection: a systematic literature review. Arch Orthop Trauma Surg. 2019 Jan;139(1):61-72. doi: 10.1007/s00402-018-3048-0. Epub 2018 Oct 20. PubMed 30343322 ↗
  • Govaert GAM, Kuehl R, Atkins BL, Trampuz A, Morgenstern M, Obremskey WT, Verhofstad MHJ, McNally MA, Metsemakers WJ; Fracture-Related Infection (FRI) Consensus Group. Diagnosing Fracture-Related Infection: Current Concepts and Recommendations. J Orthop Trauma. 2020 Jan;34(1):8-17. doi: 10.1097/BOT.0000000000001614. PubMed 31855973 ↗
  • Metsemakers WJ, Fragomen AT, Moriarty TF, Morgenstern M, Egol KA, Zalavras C, Obremskey WT, Raschke M, McNally MA; Fracture-Related Infection (FRI) consensus group. Evidence-Based Recommendations for Local Antimicrobial Strategies and Dead Space Management in Fracture-Related Infection. J Orthop Trauma. 2020 Jan;34(1):18-29. doi: 10.1097/BOT.0000000000001615. PubMed 31464858 ↗

Study documents

  • Study protocol · Jul 1, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided — Six countries are involved in the study, and they have different regulations regarding handling patient data. Therefore, researchers will assess data sharing during the data analysis phase of the study.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 20, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05467644
Lead sponsor
Manoel Victorino Hospital
Collaborators
AO Trauma Latin America, Centro Médico Nacional de Occidente IMSS, University of Campinas, Brazil, Hospital Municipal Miguel Couto, Hospital Italiano de Buenos Aires, Hospital Pablo Tobón Uribe
Responsible party
Matheus Lemos Azi (Principal Investigator, Manoel Victorino Hospital) — Principal investigator
First posted
Jul 20, 2022
Start date
Jan 1, 2021
Primary completion
Sep 1, 2022 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Jul 20, 2022

Study contacts

Matheus Azi, PhD
Contact
matheus.azi@saude.ba.gov.br
+557132541250
Nilma Caldas
Contact
residenciamedicahmv@gmail.com
+557132541250

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion